Latest Period
Q2 2026
Security Snapshot
CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) Institutional Ownership
CUSIP: 14888U101
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
390
Shares (Excl. Options)
107,631,985
Price
$31.43
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- CPRX
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 107,631,985
- Total 13F value
- $3,376,805,293
- Portfolio coverage rank
- 0.01%
- Share change
- +3,080,236
- Value change
- +$174,170,234
- Number of holders
- 390
- Shares outstanding
- 123,180,519
- SEC-reported price per share
- $31.49
- Insider filing price
- $31.49
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock is tracked under CUSIP 14888U101.
- 390 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 381 to 390 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $2,588,669,865 to $3,376,805,293.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 390 institutions filings for Q2 2026.
Security key
14888U101
Latest holder period
Q2 2026
13F holders
390
13D/G owners
3
CIK / CUSIP context first
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 14888U101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
CPRX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 14% | $399,180,432 | 16,892,951 | BlackRock, Inc. | 31 Mar 2025 | |||
| STATE STREET CORP | 5.2% | $126,186,124 | 6,405,387 | STATE STREET CORPORATION | 30 Sep 2025 | |||
| Flynn James E | 2.6% | $74,033,050 | 3,133,011 | Deerfield Mgmt, L.P. | 31 Dec 2024 |
As of 30 Jun 2026, 390 institutional investors reported holding 107,631,985 shares of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX). This represents 87% of the company’s total 123,180,519 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
65%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 16% | 19,158,785 | +2% | 0.01% | $602,160,611 |
| STATE STREET CORP | 6.2% | 7,627,036 | +11% | 0.01% | $239,718,530 |
| AMERICAN CENTURY COMPANIES INC | 4.5% | 5,553,921 | +34% | 0.08% | $174,559,737 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2% | 5,135,345 | +0.25% | 0% | $161,403,893 |
| DIMENSIONAL FUND ADVISORS LP | 3% | 3,634,171 | +6% | 0.02% | $114,222,631 |
| GLAZER CAPITAL, LLC | 2.9% | 3,602,865 | 2.8% | $113,238,000 | |
| JPMORGAN CHASE & CO | 2.6% | 3,169,902 | +579% | 0.01% | $99,885,374 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 3,150,256 | +6% | 0.01% | $99,029,648 |
| HBK INVESTMENTS L P | 2.3% | 2,820,302 | 1% | $88,642,092 | |
| MORGAN STANLEY | 2.2% | 2,760,358 | +2.7% | 0% | $86,758,074 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2% | 2,428,922 | -1.9% | 0% | $76,341,018 |
| Jupiter Topco LLC | 1.8% | 2,277,822 | 0% | 0.03% | $71,602,630 |
| Qube Research & Technologies Ltd | 1.8% | 2,254,355 | +446% | 0.08% | $70,854,378 |
| RENAISSANCE TECHNOLOGIES LLC | 1.7% | 2,136,077 | -9% | 0.09% | $67,136,900 |
| Boston Partners | 1.3% | 1,658,936 | -3.1% | 0.05% | $52,152,535 |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1.3% | 1,602,557 | 3.4% | $50,368,367 | |
| UBS Group AG | 1.2% | 1,453,726 | +47% | 0.01% | $45,690,609 |
| NORTHERN TRUST CORP | 1.1% | 1,330,520 | +7.5% | 0% | $41,818,244 |
| BANK OF AMERICA CORP /DE/ | 1.1% | 1,311,366 | -57% | 0% | $41,216,233 |
| GOLDMAN SACHS GROUP INC | 0.97% | 1,194,200 | +21% | 0% | $37,533,706 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.94% | 1,159,456 | -19% | 0% | $36,441,702 |
| Polar Asset Management Partners Inc. | 0.93% | 1,150,300 | 0.66% | $36,153,929 | |
| MILLENNIUM MANAGEMENT LLC | 0.87% | 1,068,724 | +39% | 0.02% | $33,589,995 |
| WATER ISLAND CAPITAL LLC | 0.76% | 933,819 | 3.1% | $29,349,931 | |
| MARSHALL WACE, LLP | 0.74% | 911,700 | +352% | 0.02% | $28,654,732 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 107,631,985 | $3,376,805,293 | +$174,170,234 | $31.43 | 390 |
| 2026 Q1 | 104,585,733 | $2,588,669,865 | +$16,178,726 | $24.76 | 381 |
| 2025 Q4 | 103,990,575 | $2,425,290,703 | +$6,403,302 | $23.34 | 374 |
| 2025 Q3 | 103,323,297 | $2,035,619,506 | +$33,916,547 | $19.70 | 357 |
| 2025 Q2 | 101,339,025 | $2,199,165,165 | +$74,610,948 | $21.70 | 360 |
| 2025 Q1 | 97,995,812 | $2,374,736,976 | +$45,703,179 | $24.25 | 365 |
| 2024 Q4 | 97,462,582 | $2,034,900,504 | +$38,258,566 | $20.87 | 333 |
| 2024 Q3 | 95,380,838 | $1,896,646,482 | -$35,292,712 | $19.88 | 312 |
| 2024 Q2 | 96,983,113 | $1,502,403,827 | +$11,987,767 | $15.49 | 269 |
| 2024 Q1 | 96,270,213 | $1,534,339,181 | +$191,142,132 | $15.94 | 268 |
| 2023 Q4 | 84,453,649 | $1,419,515,333 | +$62,962,605 | $16.81 | 259 |
| 2023 Q3 | 81,157,485 | $948,788,519 | -$23,397,502 | $11.69 | 254 |
| 2023 Q2 | 82,218,793 | $1,104,943,728 | -$95,298,712 | $13.44 | 243 |
| 2023 Q1 | 88,787,264 | $1,472,124,820 | +$71,196,268 | $16.58 | 256 |
| 2022 Q4 | 84,107,036 | $1,564,456,429 | -$12,268,287 | $18.60 | 252 |
| 2022 Q3 | 85,176,091 | $1,093,105,879 | +$187,635,691 | $12.83 | 220 |
| 2022 Q2 | 75,651,199 | $530,307,280 | +$37,811,777 | $7.01 | 175 |
| 2022 Q1 | 70,838,632 | $586,598,135 | +$41,265,648 | $8.29 | 181 |
| 2021 Q4 | 66,018,446 | $446,683,816 | +$3,690,649 | $6.77 | 160 |
| 2021 Q3 | 65,162,167 | $345,106,769 | -$2,224,745 | $5.30 | 138 |
| 2021 Q2 | 65,482,202 | $376,526,274 | -$10,746,528 | $5.75 | 137 |
| 2021 Q1 | 67,671,701 | $311,885,548 | +$10,809,324 | $4.61 | 130 |
| 2020 Q4 | 66,576,359 | $222,408,153 | -$12,651,094 | $3.34 | 131 |
| 2020 Q3 | 67,907,092 | $201,992,589 | +$603,491 | $2.97 | 140 |
| 2020 Q2 | 64,719,712 | $299,102,386 | -$2,974,113 | $4.62 | 138 |